Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Claxton

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Health Economics|May 29, 1999
Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticalsK Claxton
Journal of Health Economics|October 28, 1999
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologiesK Claxton
Journal of Wound Care|November 28, 2006
Reviewing the evidence for wound bed preparationC Dowsett, K Claxton
Health Economics|November 1, 1996
An economic approach to clinical trial design and research priority-settingK Claxton, J Posnett
Journal of Health Economics|September 18, 2001
A dynamic programming approach to the efficient design of clinical trialsK Claxton, K M Thompson
Journal of Medical Ethics|July 4, 2006
Wickedness or folly? The ethics of NICE's decisionsK Claxton, A J Culyer
Health Economics|May 29, 1999
Redefining the analytical approach to pharmacoeconomicsB R Luce, K Claxton
Journal of Medical Ethics|August 1, 2008
Not a NICE fallacy: a reply to Dr QuigleyK Claxton, A J Culyer
Health Economics|December 18, 2001
Representing uncertainty: the role of cost-effectiveness acceptability curvesE Fenwick, K Claxton, M Sculpher
Pharmacoeconomics|September 8, 2000
Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of applicationM Sculpher, E Fenwick, K Claxton
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Health Economics|May 29, 1999
Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticalsK Claxton
Journal of Health Economics|October 28, 1999
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologiesK Claxton
Journal of Wound Care|November 28, 2006
Reviewing the evidence for wound bed preparationC Dowsett, K Claxton
Health Economics|November 1, 1996
An economic approach to clinical trial design and research priority-settingK Claxton, J Posnett
Journal of Health Economics|September 18, 2001
A dynamic programming approach to the efficient design of clinical trialsK Claxton, K M Thompson
Journal of Medical Ethics|July 4, 2006
Wickedness or folly? The ethics of NICE's decisionsK Claxton, A J Culyer
Health Economics|May 29, 1999
Redefining the analytical approach to pharmacoeconomicsB R Luce, K Claxton
Journal of Medical Ethics|August 1, 2008
Not a NICE fallacy: a reply to Dr QuigleyK Claxton, A J Culyer
Health Economics|December 18, 2001
Representing uncertainty: the role of cost-effectiveness acceptability curvesE Fenwick, K Claxton, M Sculpher
Pharmacoeconomics|September 8, 2000
Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of applicationM Sculpher, E Fenwick, K Claxton
Pageof 3